Item Type | Name |
Concept
|
Catalysis
|
Concept
|
Cytochrome P-450 Enzyme System
|
Concept
|
Enzyme Inhibitors
|
Concept
|
Enzyme Activation
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
Concept
|
Enzyme Induction
|
Concept
|
DNA Repair Enzymes
|
Concept
|
Gene Expression Regulation, Enzymologic
|
Academic Article
|
O6-alkylguanine-DNA alkyltransferase inactivation by ester prodrugs of O6-benzylguanine derivatives and their rate of hydrolysis by cellular esterases.
|
Academic Article
|
Effects of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agents.
|
Academic Article
|
Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.
|
Academic Article
|
Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2.
|
Academic Article
|
Inhibition of O(6)-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats.
|
Academic Article
|
Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases.
|
Academic Article
|
O6-benzylguanine and its role in chemotherapy.
|
Academic Article
|
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
|
Academic Article
|
In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo.
|
Academic Article
|
Role of cytochrome P450 isoenzymes in metabolism of O(6)-benzylguanine: implications for dacarbazine activation.
|
Academic Article
|
Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogues in nonhuman primates.
|
Academic Article
|
Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanine.
|
Academic Article
|
Effect of O6-benzylguanine on nitrogen mustard-induced toxicity, apoptosis, and mutagenicity in Chinese hamster ovary cells.
|
Academic Article
|
Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity.
|
Academic Article
|
Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 gene.
|
Academic Article
|
Characterization of multiple promoters in the human carboxylesterase 2 gene.
|
Academic Article
|
Inactivation of O6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy.
|
Academic Article
|
Genetic variants contributing to daunorubicin-induced cytotoxicity.
|
Academic Article
|
Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy.
|
Academic Article
|
Clinically relevant genetic variations in drug metabolizing enzymes.
|
Academic Article
|
Functional genetic screen of human diversity reveals that a methionine salvage enzyme regulates inflammatory cell death.
|
Academic Article
|
Human liver oxidative metabolism of O6-benzylguanine.
|
Academic Article
|
Pharmacokinetics and metabolism in rats of 2,4-diamino-6-benzyloxy-5- nitrosopyrimidine, an inactivator of O6-alkylguanine-DNA alkyltransferase.
|
Academic Article
|
Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells.
|
Academic Article
|
Production of antibodies to peptide sequences present in human O6-alkylguanine-DNA alkyltransferase and their use to detect this protein in cell extracts.
|
Academic Article
|
Increased killing of prostate, breast, colon, and lung tumor cells by the combination of inactivators of O6-alkylguanine-DNA alkyltransferase and N,N'-bis(2-chloroethyl)-N-nitrosourea.
|
Academic Article
|
Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferase.
|
Academic Article
|
Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase.
|
Academic Article
|
O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
|
Academic Article
|
O6-benzylguanine-mediated enhancement of nitrosourea activity in Mer- central nervous system tumor xenografts--implications for clinical trials.
|
Academic Article
|
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.
|
Academic Article
|
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma.
|
Academic Article
|
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.
|
Academic Article
|
Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity.
|
Academic Article
|
O6-benzylguanine-mediated enhancement of chemotherapy.
|
Academic Article
|
The role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide.
|
Academic Article
|
Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms.
|